Hungry for growth, Aratana takes new pet drug to market

Aratana Therapeutics, a Leawood animal health company, took its third treatment — an appetite stimulant for dogs — to market on Friday. The Leawood-based company had delayed the release of the drug, called Entyce, as the company waited for FDA approval to transfer and scale up its manufacturing. At market close, the company’s stock was valued at $6.25. The announcement pushed up the stock price in after-hour trading, to $6.95 a share as of 7 a.m. on Monday, according to Yahoo Finance. Entyce…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news